Related Experiment Video

Updated: Dec 12, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.3K

MicroRNA-222 Regulates Melanoma Plasticity

Maria Chiara Lionetti1, Filippo Cola2, Oleksandr Chepizhko3

  • 1Center for Complexity and Biosystems, Department of Environmental Science and Policy, University of Milan, via Celoria 26, 20133 Milano, Italy.

Journal of Clinical Medicine
|August 14, 2020
PubMed

Insights

This study identifies hsa-mir-222 as a key factor in melanoma cell plasticity. Targeting this microRNA could impair cancer stem cell-driven phenotypic switching and melanoma metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Computational Biology

Background:

  • Melanoma is an aggressive cancer characterized by high resistance and metastatic potential.
  • Cellular plasticity is a key driver of melanoma metastasis, but its underlying molecular mechanisms remain unclear.
  • Understanding these mechanisms is crucial for developing effective melanoma therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms controlling melanoma cell plasticity.
  • To identify potential therapeutic targets for inhibiting phenotypic switching in melanoma.
  • To combine mathematical modeling with experimental validation.

Main Methods:

  • Development of a mathematical model to simulate phenotypic switching in melanoma.
  • Experimental validation using IgR39 human melanoma cells.
  • Analysis of the role of specific molecular factors, including microRNAs, in regulating cell plasticity.

Main Results:

  • The mathematical model indicated that a cancer stem cell subpopulation inhibits phenotypic switching in other melanoma cells.
  • Experimental results identified hsa-mir-222 as a critical factor facilitating this stem cell-mediated process.
  • hsa-mir-222 plays a significant role in maintaining melanoma cell plasticity.

Conclusions:

  • hsa-mir-222 is a key regulator of melanoma cell plasticity and cancer stem cell behavior.
  • Targeting hsa-mir-222 presents a potential therapeutic strategy to impair melanoma cell switching and metastasis.
  • This research provides novel insights into melanoma progression and offers guidance for future therapeutic development.
Keywords:
cancer stem cellshsa-mir-222kinetic equationsmelanomaphenotypic switchingreaction diffusiontumor plasticity

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.7K
Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

5.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.1K